Kedrion And Kamada Receive FDA Approval Of KEDRAB For Post-Exposure Prophylaxis Against Rabies Infection Post author:Sam Post published:August 24, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like ProQR Therapeutics Spins Out CNS-Focused Biotech, September 11, 2017 Little reMYND Forges 350M+ Euros Tie-Up With Drug Giant Novo Nordisk December 13, 2017 FDA Declares Pfizer's Atopic Dermatitis Drug a Breakthrough February 13, 2018